Skip to main content
Book cover

Core Concepts in Hypertension in Kidney Disease pp 107–132Cite as

Hypertension in Pregnancy

  • 820 Accesses

Abstract

Hypertensive disorders complicate up to 10 % of pregnancies, and are a major cause of maternal and neonatal morbidity and mortality. Hypertensive disorders of pregnancy include four categories: chronic hypertension, gestational hypertension, preeclampsia, and superimposed preeclampsia. The diagnosis and management of hypertension in pregnancy requires a special approach with attention toward the maternal and fetal effects of both the disease and the treatment. This chapter reviews the pathogenesis, epidemiology, diagnosis, management, and prognosis of hypertensive disorders of pregnancy.

Keywords

  • Pregnancy
  • Preeclampsia
  • Gestational hypertension
  • Preterm birth
  • Intrauterine growth restriction

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4939-6436-9_6
  • Chapter length: 26 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   84.99
Price excludes VAT (USA)
  • ISBN: 978-1-4939-6436-9
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   109.99
Price excludes VAT (USA)
Hardcover Book
USD   149.99
Price excludes VAT (USA)
Learn about institutional subscriptions
Fig. 6.1

References

  1. Poppas A, Shroff SG, Korcarz CE, Hibbard JU, Berger DS, Lindheimer MD, et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation. 1997;95(10):2407–15.

    CAS  PubMed  CrossRef  Google Scholar 

  2. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54(6):2056–63.

    CAS  PubMed  CrossRef  Google Scholar 

  3. Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980;68(1):97–104.

    CAS  PubMed  CrossRef  Google Scholar 

  4. Desai DK, Moodley J, Naidoo DP. Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy. Obstet Gynecol. 2004;104(1):20–9.

    PubMed  CrossRef  Google Scholar 

  5. Varga I, Rigo Jr J, Somos P, Joo JG, Nagy B. Analysis of maternal circulation and renal function in physiologic pregnancies; parallel examinations of the changes in the cardiac output and the glomerular filtration rate. J Matern Fetal Med. 2000;9(2):97–104.

    CAS  PubMed  Google Scholar 

  6. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol. 2000;24(1):11–4.

    CAS  PubMed  CrossRef  Google Scholar 

  7. Elsheikh A, Creatsas G, Mastorakos G, Milingos S, Loutradis D, Michalas S. The renin-aldosterone system during normal and hypertensive pregnancy. Arch Gynecol Obstet. 2001;264(4):182–5.

    CAS  PubMed  CrossRef  Google Scholar 

  8. Khraibi AA. Renal interstitial hydrostatic pressure and sodium excretion in hypertension and pregnancy. J Hypertens Suppl. 2002;20(3):S21–7.

    CAS  PubMed  Google Scholar 

  9. Davison JM. Edema in pregnancy. Kidney Int Suppl. 1997;59:S90–6.

    CAS  PubMed  Google Scholar 

  10. Paller MS. Decreased pressor responsiveness in pregnancy: studies in experimental animals. Am J Kidney Dis. 1987;9(4):308–11.

    CAS  PubMed  CrossRef  Google Scholar 

  11. Gant NF, Chand S, Whalley PJ, MacDonald PC. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol. 1974;43(6):854.

    CAS  PubMed  Google Scholar 

  12. Cunningham FG, Cox K, Gant NF. Further observations on the nature of pressor responsivity to angiotensin II in human pregnancy. Obstet Gynecol. 1975;46(5):581–3.

    CAS  PubMed  Google Scholar 

  13. Conrad KP, Jeyabalan A, Danielson LA, Kerchner LJ, Novak J. Role of relaxin in maternal renal vasodilation of pregnancy. Ann N Y Acad Sci. 2005;1041:147–54.

    CAS  PubMed  CrossRef  Google Scholar 

  14. Conrad KP. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J Soc Gynecol Investig. 2004;11(7):438–48.

    CAS  PubMed  CrossRef  Google Scholar 

  15. Conrad KP, Davison JM. The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am J Physiol Renal Physiol. 2014;306(10):F1121–35.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  16. Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134.e1–8.

    Google Scholar 

  17. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med. 1996;335(4):257–65.

    CAS  PubMed  CrossRef  Google Scholar 

  18. Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy. 2010;29(3):294–300.

    PubMed  CrossRef  Google Scholar 

  19. Riester A, Reincke M. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol. 2015;172(1):R23–30.

    CAS  PubMed  CrossRef  Google Scholar 

  20. Ledoux F, Genest J, Nowaczynski W, Kuchel O, Lebel M. Plasma progesterone and aldosterone in pregnancy. Can Med Assoc J. 1975;112(8):943–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Wyckoff JA, Seely EW, Hurwitz S, Anderson BF, Lifton RP, Dluhy RG. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension. 2000;35(2):668–72.

    CAS  PubMed  CrossRef  Google Scholar 

  22. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266–81.

    CAS  PubMed  CrossRef  Google Scholar 

  23. Kamoun M, Mnif MF, Charfi N, Kacem FH, Naceur BB, Mnif F, et al. Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies. Am J Med Sci. 2014;347(1):64–73.

    PubMed  CrossRef  Google Scholar 

  24. Cabassi A, Rocco R, Berretta R, Regolisti G, Bacchi-Modena A. Eplerenone use in primary aldosteronism during pregnancy. Hypertension. 2012;59(2):e18–9.

    CAS  PubMed  CrossRef  Google Scholar 

  25. Easterling TR, Brateng D, Goldman ML, Strandness DE, Zaccardi MJ. Renal vascular hypertension during pregnancy. Obstet Gynecol. 1991;78(5 Pt 2):921–5.

    CAS  PubMed  Google Scholar 

  26. Thorsteinsdottir B, Kane GC, Hogan MJ, Watson WJ, Grande JP, Garovic VD. Adverse outcomes of renovascular hypertension during pregnancy. Nat Clin Pract Nephrol. 2006;2(11):651–6.

    PubMed  CrossRef  Google Scholar 

  27. Hayashida M, Watanabe N, Imamura H, Kumazaki S, Kitabayashi H, Takahashi W, et al. Congenital solitary kidney with renovascular hypertension diagnosed by means of captopril-enhanced renography and magnetic resonance angiography. Int Heart J. 2005;46(2):347–53.

    PubMed  CrossRef  Google Scholar 

  28. Del Giudice A, Bisceglia M, D’Errico M, Gatta G, Nardella M, Ciavarella GP, et al. Extra-adrenal functional paraganglioma (phaeochromocytoma) associated with renal-artery stenosis in a pregnant woman. Nephrol Dial Transplant. 1998;13(11):2920–3.

    PubMed  CrossRef  Google Scholar 

  29. Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg. 2013;100(2):182–90.

    CAS  PubMed  CrossRef  Google Scholar 

  30. Song Y, Liu J, Li H, Zeng Z, Bian X, Wang S. Outcomes of concurrent Caesarean delivery and pheochromocytoma resection in late pregnancy. Intern Med J. 2013;43(5):588–91.

    CAS  PubMed  CrossRef  Google Scholar 

  31. Campino C, Trejo P, Carvajal CA, Vecchiola A, Valdivia C, Fuentes CA, et al. Pregnancy normalized familial hyperaldosteronism type I: a novel role for progesterone? J Hum Hypertens. 2015;29(2):138–9.

    CAS  PubMed  CrossRef  Google Scholar 

  32. Vecchiola A, Lagos CF, Fuentes CA, Allende F, Campino C, Valdivia C, et al. Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro. Reprod Biol Endocrinol. 2013;11:76.

    PubMed  PubMed Central  CrossRef  CAS  Google Scholar 

  33. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000;289(5476):119–23.

    CAS  PubMed  CrossRef  Google Scholar 

  34. Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab. 2005;90(5):3077–83.

    CAS  PubMed  CrossRef  Google Scholar 

  35. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;339(10):667–71.

    CAS  PubMed  CrossRef  Google Scholar 

  36. Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  37. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  38. Mostello D, Catlin TK, Roman L, Holcomb Jr WL, Leet T. Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol. 2002;187(2):425–9.

    PubMed  CrossRef  Google Scholar 

  39. Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. Maternal complications in women with chronic hypertension: a population-based cohort study. Acta Obstet Gynecol Scand. 2005;84(5):419–24.

    PubMed  CrossRef  Google Scholar 

  40. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 1991;266(2):237–41.

    CAS  PubMed  CrossRef  Google Scholar 

  41. Clowse MEB, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127.e1-e6.

    Google Scholar 

  42. Krotz S, Fajardo J, Ghandi S, Patel A, Keith LG. Hypertensive disease in twin pregnancies: a review. Twin Res. 2002;5(1):8–14.

    PubMed  CrossRef  Google Scholar 

  43. Ness RB, Markovic N, Bass D, Harger G, Roberts JM. Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol. 2003;102(6):1366–71.

    PubMed  Google Scholar 

  44. Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, et al. Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol. 2004;190(4):1091–7.

    PubMed  CrossRef  Google Scholar 

  45. Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW. A sister’s risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol. 2005;193(3 Suppl 1):965–72.

    PubMed  CrossRef  Google Scholar 

  46. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ. 2013;347:f6564.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  47. Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2013;209(4):327.e1–17.

    Google Scholar 

  48. Gynecologists ACoOa. ACOG Practice Bulletin No. 125: chronic hypertension in pregnancy. Obstet Gynecol. 2012;119(2 Pt 1):396–407.

    Google Scholar 

  49. August P, Helseth G, Cook EF, Sison C. A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy. Am J Obstet Gynecol. 2004;191(5):1666–72.

    PubMed  CrossRef  Google Scholar 

  50. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol. 1996;103(2):123–9.

    CAS  PubMed  CrossRef  Google Scholar 

  51. Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(10):695–703.

    PubMed  CrossRef  Google Scholar 

  52. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2 Pt 1):402–14.

    PubMed  CrossRef  Google Scholar 

  53. Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141–6.

    PubMed  CrossRef  Google Scholar 

  54. Hofmeyr G, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 2007;114(8):933–43.

    CAS  PubMed  CrossRef  Google Scholar 

  55. Hofmeyr GJ, Belizán JM, von Dadelszen P. Group CaP-eCS. Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. BJOG. 2014;121(8):951–7.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  56. Wen SW, Gaudet L, Champagne J, White RR, Rybak N, Walker M. [301-POS]: Effect of folic acid supplementation in pregnancy on preeclampsia—Folic Acid Clinical Trial (FACT). Pregnancy Hypertens. 2015;5(1):149.

    Google Scholar 

  57. Tabesh M, Salehi-Abargouei A, Esmaillzadeh A. Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(8):3165–73.

    CAS  PubMed  CrossRef  Google Scholar 

  58. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. Br Med J (Clin Res Ed). 1985;290(6461):17–23.

    CAS  CrossRef  Google Scholar 

  59. Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev. 2005;4, CD005548.

    PubMed  Google Scholar 

  60. Aune D, Saugstad OD, Henriksen T, Tonstad S. Physical activity and the risk of preeclampsia: a systematic review and meta-analysis. Epidemiology. 2014;25(3):331–43.

    PubMed  CrossRef  Google Scholar 

  61. Gynecologists ACoOa, Pregnancy TFoHi. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.

    Google Scholar 

  62. Weight gain during pregnancy: reexamining the guidelines. Washington: Institute of Medicine; 2009.

    Google Scholar 

  63. Truong YN, Yee LM, Caughey AB, Cheng YW. Weight gain in pregnancy: does the Institute of Medicine have it right? Am J Obstet Gynecol. 2015;212(3):362.e1–8.

    Google Scholar 

  64. Kotchen TA, Cowley AW, Frohlich ED. Salt in health and disease—a delicate balance. N Engl J Med. 2013;368(26):2531–2.

    CAS  PubMed  CrossRef  Google Scholar 

  65. National Heart, Lung, and Blood Institute Task Force Report on Research in Prevention of Cardiovascular Disease 2001.

    Google Scholar 

  66. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.

    CAS  PubMed  CrossRef  Google Scholar 

  67. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ. 1999;318(7194):1332–6.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  68. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2001;2, CD002252.

    PubMed  Google Scholar 

  69. Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol. 2000;96(5 Pt 2):849–60.

    CAS  PubMed  Google Scholar 

  70. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2, CD002252.

    PubMed  Google Scholar 

  71. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355(9198):87–92.

    CrossRef  Google Scholar 

  72. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003:289.19.2560.

    Google Scholar 

  73. Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407–17.

    CAS  PubMed  CrossRef  Google Scholar 

  74. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol. 1998;105(11):1177–84.

    CAS  PubMed  CrossRef  Google Scholar 

  75. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186(1):66–71.

    PubMed  CrossRef  Google Scholar 

  76. Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG. 2003;110(9):831–6.

    CAS  PubMed  CrossRef  Google Scholar 

  77. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–99.

    PubMed  CrossRef  Google Scholar 

  78. Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950–5.

    PubMed  Google Scholar 

  79. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 1991;4(8):700–8.

    CAS  PubMed  Google Scholar 

  80. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1–7.

    CAS  PubMed  CrossRef  Google Scholar 

  81. Ashworth JR, Warren AY, Baker PN, Johnson IR. Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol. 1997;104(10):1152–8.

    CAS  PubMed  CrossRef  Google Scholar 

  82. Brown MA, Wang J, Whitworth JA. The renin-angiotensin-aldosterone system in pre-eclampsia. Clin Exp Hypertens. 1997;19(5–6):713–26.

    CAS  PubMed  CrossRef  Google Scholar 

  83. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–44.

    PubMed  CrossRef  Google Scholar 

  84. Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003;188(1):264–8.

    PubMed  CrossRef  Google Scholar 

  85. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Committee SHG. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(7):575–6.

    PubMed  CrossRef  Google Scholar 

  86. HDP CPG Working Group. Association of Ontario Midwives. Hypertensive Disorders of Pregnancy. Clinical Practice Guideline No. 15. Available at: http://www.aom.on.ca/Health_Care_Professionals/Clinical_Practice_Guidelines/2012.

  87. Hypertensive Disorders of Pregnancy 2013 [cited 2015 June 10, 2015].

    Google Scholar 

  88. Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One. 2014;9(12), e113715.

    PubMed  PubMed Central  CrossRef  CAS  Google Scholar 

  89. National Institute for Health and Care Excellence (NICE): hypertension in pregnancy: the management of hypertensive disorders during pregnancy 2010 [May 2015]. Available at: http://www.nice.org.uk/guidance/cg107/chapter/1-recommendations.

  90. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171(3):818–22.

    CAS  PubMed  CrossRef  Google Scholar 

  91. Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol. 1985;152(1):32–7.

    CAS  PubMed  CrossRef  Google Scholar 

  92. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979–88.

    PubMed  CrossRef  Google Scholar 

  93. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877–90.

    PubMed  CrossRef  Google Scholar 

  94. Ascarelli MH, Johnson V, McCreary H, Cushman J, May WL, Martin JN. Postpartum preeclampsia management with furosemide: a randomized clinical trial. Obstet Gynecol. 2005;105(1):29–33.

    CAS  PubMed  CrossRef  Google Scholar 

  95. Chames MC, Livingston JC, Ivester TS, Barton JR, Sibai BM. Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol. 2002;186(6):1174–7.

    PubMed  CrossRef  Google Scholar 

  96. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol. 2009;200(1):58.e1–e8.

    Google Scholar 

  97. Edlow AG, Srinivas SK, Elovitz MA. Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2009;200(5):e60–2.

    PubMed  CrossRef  Google Scholar 

  98. Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol. 1995;102(11):876–81.

    CAS  PubMed  CrossRef  Google Scholar 

  99. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918–30.

    PubMed  CrossRef  Google Scholar 

  100. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  101. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57(12):1404–23.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  102. Vikse BE, Irgens LM, Bostad L, Iversen BM. Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol. 2006;17(3):837–45.

    PubMed  CrossRef  Google Scholar 

  103. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9.

    CAS  PubMed  CrossRef  Google Scholar 

  104. Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Reisæter AV, Skjærven R. Familial factors in the association between preeclampsia and later ESRD. Clin J Am Soc Nephrol. 2012;7(11):1819–26.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  105. Hertig A, Watnick S, Strevens H, Boulanger H, Berkane N, Rondeau E. How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Clin Pract Nephrol. 2008;4(9):503–9.

    PubMed  CrossRef  Google Scholar 

  106. Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG. 2014;121(10):1210–8. discussion 20.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  107. Podymow T, August P, Umans JG. Antihypertensive therapy in pregnancy. Semin Nephrol. 2004;24(6):616–25.

    PubMed  CrossRef  Google Scholar 

  108. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2003;3, CD002863.

    PubMed  Google Scholar 

  109. Smith P, Anthony J, Johanson R. Nifedipine in pregnancy. BJOG. 2000;107(3):299–307.

    CAS  PubMed  CrossRef  Google Scholar 

  110. Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation. 2014;130(8):703–14.

    PubMed  CrossRef  Google Scholar 

  111. Morton A, Panitz B, Bush A. Eplerenone for gitelman syndrome in pregnancy. Nephrology (Carlton). 2011;16(3):349.

    CrossRef  Google Scholar 

  112. Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012;60(2):444–50.

    CAS  PubMed  CrossRef  Google Scholar 

  113. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–51.

    CAS  PubMed  CrossRef  Google Scholar 

  114. Serreau R, Luton D, Macher MA, Delezoide AL, Garel C, Jacqz-Aigrain E. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG. 2005;112(6):710–2.

    CAS  PubMed  CrossRef  Google Scholar 

  115. Hanff LM, Vulto AG, Bartels PA, Roofthooft DW, Bijvank BN, Steegers EA, et al. Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients. J Hypertens. 2005;23(12):2319–26.

    CAS  PubMed  CrossRef  Google Scholar 

  116. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2012;119(1):78–85.

    CAS  PubMed  CrossRef  Google Scholar 

  117. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955–60.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  118. Lalani S, Firoz T, Magee LA, Sawchuck D, Payne B, Gordon R, et al. Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists. J Obstet Gynaecol Can. 2013;35(3):215–23.

    PubMed  CrossRef  Google Scholar 

  119. Hennessy A, Thornton CE, Makris A, Ogle RF, Henderson-Smart DJ, Gillin AG, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. Aust N Z J Obstet Gynaecol. 2007;47(4):279–85.

    PubMed  CrossRef  Google Scholar 

  120. Beardmore KS, Morris JM, Gallery ED. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy. 2002;21(1):85–95.

    CAS  PubMed  CrossRef  Google Scholar 

  121. National Library of Medicine, Drugs and Lactation Database (LactMed) 2015 [6/22/2015]. http://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm.

Download references

Author information

Authors and Affiliations

  1. Associate Professor of Medicine, University of South Florida Morsani College of Medicine, Lehigh Valley Health Network, 1230 South Cedar Crest Blvd., Suite 301, Allentown, PA, 18103, USA

    Sharon Maynard MD

Authors
  1. Sharon Maynard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sharon Maynard MD .

Editor information

Editors and Affiliations

  1. Global and Continuing Education, Harvard Medical School, Boston, Massachusetts, USA

    Ajay K. Singh

  2. VA Medical Center, Indiana University School of Medicine, Indianapolis, Indiana, USA

    Rajiv Agarwal

Rights and permissions

Reprints and Permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Maynard, S. (2016). Hypertension in Pregnancy. In: Singh, A., Agarwal, R. (eds) Core Concepts in Hypertension in Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6436-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6436-9_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6434-5

  • Online ISBN: 978-1-4939-6436-9

  • eBook Packages: MedicineMedicine (R0)